Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report

Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report

Saved in:
Bibliographic Details
Main Authors: Katie Foug, Stephanie L. Skala, Erica Stein, Kevin Reynolds, Jean Siedel, Shitanshu Uppal
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Gynecologic Oncology Reports
Subjects:
PARP inhibitor
Uterine adenosarcoma
Somatic BRCA mutation
Recurrent disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578925000499
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2352-5789

Similar Items